Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2025

Mar 15, 2025

35221_dirs_2025-03-14_4f468041-3429-4fd3-93f1-676f09f63f06.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2025-02-21

Reporting Person: Tasso Partners, LLC (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2574350 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Prefunded Warrant $0.001 2030-02-18 Common Stock (53974) Direct

Footnotes

F1: The prefunded warrant certificate provides that warrant becomes exercisable upon the date that the issuer's stockholders approve, for the purposes of the rules of The Nasdaq Stock Market LLC, the issuance of shares of common stock upon exercise of the prefunded warrant.